CD8A and neoplasm: A recent study further showed that PP2A inhibition with LB-100 enhanced the responses of murine tumours to ICB, potentially through activation of mTORC1 which resulted in reduced differentiation toward Tregs and increased tumour infiltrating CD8+ T cells32.